Taken together, our data indicate that IL-39 infusion enhances T cell activation and GC B cell differentiation, while reducing the proportion of CD4+CD8+ double-positive cells in the thymus, thereby aggravating lupus-like cGVHD. Here, CD4 is linked to systemic lupus erythematosus.